Q BioMed Inc (QBIO)

[Thunderstruck]

QBIO...Q BioMed Stock Price, News & Analysis (OTCMKTS:QBIO)
$0.50+0.03 (+6.38 %)
(As of 09/27/2019 04:00 PM ET)
ADD COMPARE
Today's Range$0.4550Now: $0.50
?
$0.50
50-Day Range$0.48MA: $0.93
?
$1.15
52-Week Range$0.4440Now: $0.50
?
$3.37
Volume34,750 shs
Average Volume37,959 shs
Market Capitalization$7.52 million
P/E RatioN/A
Dividend YieldN/A
Beta3.97
Profile
Analyst Ratings
Advanced Chart
Earnings
Financials
Insider Trades
Headlines
SEC Filings
Social Media




Email
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; BM-001 for the treatment of rare pediatric nonverbal autism spectrum disorder; and Uttroside-B for liver cancer. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was founded in 2013 and is based in New York, New York.